1. Letters to the Editor Anthology: An e-Supplement Resource

   • Mark Roh
   • Deborah Whippen
   • Charles Balch

   Health Services Research and Global Oncology 22 November 2017 Pages: 529 - 529

2. Thank You to Annals of Surgical Oncology Expert Reviewer Community

   • Mark Roh
   • Deborah Whippen
   • Charles Balch

   Health Services Research and Global Oncology 22 November 2017 Pages: 530 - 545

3. The Changing Face of Surgical Oncology

   • Walter Lawrence Jr

   Health Services Research and Global Oncology 25 October 2017 Pages: 546 - 548

4. Comment on: Global Cancer Consortiums: Moving from Consensus to Practice

   • M. Silvina Frech
   • Lisa M. Stevens

   Health Services Research and Global Oncology 22 November 2017 Pages: 549 - 549

5. Reply: Global Cancer Consortiums: Moving from Consensus to Practice

   • André M. Ilbawi
   • Benjamin O. Anderson

   Health Services Research and Global Oncology 20 November 2017 Pages: 550 - 550

6. Long-Term Results of Thoraco-Pleuro-Pneumonectomy (TPP) for Recurrent Thoracic Sarcomas

   • U. Pastorino
   • P. Scanagatta
   • A. Gronchi

   Bone and Soft Tissue Sarcomas Open access 20 November 2017 Pages: 551 - 554

   

7. Sized Influences Nodal Status in Women Aged #70 with Endocrine Responsive Breast Cancer

   • Florian Fitzal
   • Ruth Helfgott
   • Michael Gnant

   Breast Oncology 20 November 2017 Pages: 555 - 556

8. Using Size and Grade to Identify Women Aged ≥ 70 Years with Endocrine-Responsive Breast Cancer at Low Risk of Nodal Positivity

   • Judy C. Boughey
   • Tanya L. Hoskin
   • Elizabeth B. Habermann

   Breast Oncology 30 October 2017 Pages: 557 - 558

9. Comment on “Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy”

   • S. Vignes
   • H. Brorson

   Breast Oncology 16 October 2017 Pages: 559 - 560

   

10. Response to “Complications in DIEP Flap Breast Reconstruction after Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral and Bilateral Reconstructions”

    • Niall M. McInerney
    • Anne C. O’Neill
    • Stefan O. P. Hofer

    Breast Oncology 16 November 2017 Pages: 561 - 562

11. Reply to “Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions”

    • Ryckie G. Wade
    • Sergio Razzano
    • Andrea Figus

    Breast Oncology 07 November 2017 Pages: 563 - 565

    

12. Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial

    • Daniel Rea
    • Adele Francis
    • Jennie Young

    Breast Oncology 28 November 2017 Pages: 566 - 567

13. Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial: A Reply

    • Melissa Pilewskie
    • Kimberly J. Van Zee
    • Monica Morrow

    Breast Oncology 16 November 2017 Pages: 568 - 569

14. Vitamin D Levels Affect Breast Cancer Survival Rates

    • William B. Grant

    Breast Oncology 06 November 2017 Pages: 570 - 571

15. Vitamin D Levels Affect Breast Cancer Survival Rates: A Reply

    • Curtis J. Wray

    Breast Oncology 25 October 2017 Pages: 572 - 572

16. Comments on “An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer”

    • Maryam Khoubnasabjafari
    • Khalil Ansarin
    • Abolghasem Jouyban

    Thoracic Oncology 30 October 2017 Pages: 573 - 576

    

17. Reply to An Investigation Into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products for Patients with Breast Cancer

    • Nedret Kılıç

    Breast Oncology 30 October 2017 Pages: 577 - 577

18. Response to “The CUBE Technique: Continuous Ultrasound-Guided Breast Excision,” Published in August 2014 by Tummel et al. Amsterdam, 28th January 2015

    • N. M. A. Krekel
    • M. H. Haloua
    • On Behalf of Our Study Group

    Breast Oncology 07 November 2017 Pages: 578 - 578

19. Primary Locoregional Treatment in Metastatic Breast Cancer: A Reply

    • Julie E. Lang
    • Welela Tereffe
    • Gildy Babiera

    Breast Oncology 16 November 2017 Pages: 579 - 580

20. Comparison of Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-Stage Breast Cancer

    • Vassilis Pitsinis
    • Gordon C. Wishart

    Breast Oncology 27 October 2017 Pages: 581 - 582

21. Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods for the Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer: A Reply

    • Tomoharu Sugie
    • Masakazu Toi

    Breast Oncology 01 November 2017 Pages: 583 - 584

22. Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-excision Rates in Breast Cancer?

    • Alexandre Bricou
    • Rita Sakr
    • Emmanuel Barranger

    Breast Oncology 24 October 2017 Pages: 585 - 585

23. Do Lumpectomy Cavity Shaved Margins Really Not Impact Re-Excision Rates in Breast Cancer? A Reply

    • Suzanne B. Coopey
    • Michelle C. Specht

    Breast Oncology 06 November 2017 Pages: 586 - 587

24. Comment on “Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey”

    • Deborah Cragun
    • Susan Vadaparampil
    • Tuya Pal

    Breast Oncology 26 October 2017 Pages: 588 - 589

25. Refining Tumor Resection Techniques for Managing Inferior Pole Breast Malignancies

    • Mona P. Tan

    Breast Oncology 02 November 2017 Pages: 590 - 591

    

26. In Reply: Refining Tumor Resection Techniques for Managing Inferior Pole Breast Malignancies

    • Dennis R. Holmes
    • Melvin J. Silverstein

    Breast Oncology 21 November 2017 Pages: 592 - 592

27. Comment on: Sentinel Node Biopsy Using Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial

    • Emmanuel Barranger
    • Tarik Ihrai

    Breast Oncology 22 November 2017 Pages: 593 - 593

28. Simplifying Level 2 Oncoplastic Surgery for Lower Inner Quadrant Breast Cancers

    • Mona P. Tan

    Breast Oncology 01 November 2017 Pages: 594 - 595

    

29. Vitamin D Status May Explain Some of the Racial Disparities in Rectal Cancer

    • William B. Grant

    Colorectal Cancer 31 October 2017 Pages: 596 - 596

30. In Reply: Vitamin D Status May Explain Some of the Racial Disparities in Rectal Cancer

    • James R. Nitzkorski
    • Alliric I. Willis
    • Elin R. Sigurdson

    Colorectal Cancer 01 December 2017 Pages: 597 - 597

31. Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer

    • Vildan Binay Safer
    • Umut Safer
    • Cihan Top

    Colorectal Cancer 30 October 2017 Pages: 598 - 599

32. Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy

    • Ingrid Jouvin
    • Marc Pocard
    • Clarisse Eveno

    Colorectal Cancer 30 October 2017 Pages: 600 - 601

33. Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older than 70 Years; Survival Benefit at Considerable Morbidity and Mortality: A Reply

    • Konstantinos I. Votanopoulos
    • Perry Shen
    • The Wake Forest HIPEC Group

    Colorectal Cancer 13 November 2017 Pages: 602 - 602

34. Fancier and More Expensive Doesn’t Mean Better: An Argument for CT Staging of Patients with Colorectal Liver Metastases

    • Thomas A. Aloia
    • Evelyne Loyer

    Colorectal Cancer 30 October 2017 Pages: 603 - 604

35. Comment: Fancier and More Expensive Do Mean Better: An Argument for Computed Tomography Staging of Patients With Colorectal Liver Metastases

    • Kathryn Jane Fowler
    • David C. Linehan
    • Christine O. Menias

    Colorectal Cancer 22 November 2017 Pages: 605 - 606

36. Comment on: Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, Not Necrosis, Predicts Outcome

    • Hector H. Li-Chang
    • David K. Driman

    Colorectal Cancer 27 November 2017 Pages: 607 - 607

37. Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients

    • Kazuhiro Watanabe
    • Samer Salah
    • Norio Saito

    Colorectal Cancer 30 October 2017 Pages: 608 - 608

38. Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis

    • J. P. Tiernan
    • D. G. Jayne

    Colorectal Cancer 31 October 2017 Pages: 609 - 609

39. Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply

    • Stephen P. Povoski
    • Ioannis S. Hatzaras
    • Edward W. Martin Jr.

    Colorectal Cancer 30 October 2017 Pages: 610 - 611

40. The Role of Intersphincteric Resection in Very Low Rectal Cancer

    • Theodoros E. Pavlidis
    • Efstathios T. Pavlidis
    • Athanasios K. Sakantamis

    Colorectal Cancer 25 October 2017 Pages: 612 - 613

41. Comment On: Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin

    • Antonio Pinna
    • Alan S. Rosman
    • Marcovalerio Melis

    Colorectal Cancer 03 November 2017 Pages: 614 - 614

42. Comment on: Need for Differentiating Diabetes-Specific Mortality from Total Mortality when Comparing Metformin with Insulin Regarding Cancer Survival

    • Tina Fransgaard
    • Lau Caspar Thygesen
    • Ismail Gögenur

    Colorectal Cancer 02 November 2017 Pages: 615 - 615

43. Reply: “Adjuvant” Hyperthermic Intraperitoneal Chemotherapy: A Call to Action

    • David L. Morris

    Colorectal Cancer 20 November 2017 Pages: 616 - 616

44. Treatment Patterns and Outcomes for Patients with Adrenocortical Carcinoma Associated with Hospital Case Volume in the United States

    • Katherine Mallin
    • Jerri Linn Phillips
    • David P. Winchester

    Endocrine Tumors 16 November 2017 Pages: 617 - 617

45. Treatment Patterns and Outcomes for Patients with Adrenocortical Carcinoma Associated with Hospital Case Volume in the United States: A Reply

    • Lauren Gratian

    Endocrine Tumors 13 November 2017 Pages: 618 - 618

46. Comment on: Eucalcemic Parathyroid Hormone Elevation After Parathyroidectomy for Primary Sporadic Hyperparathyroidism: Risk Factors, Trend, and Outcome

    • P. V. Pradeep
    • B. R. Srikanth

    Endocrine Tumors 30 October 2017 Pages: 619 - 619

47. Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms

    • Serkan Akin
    • Ömer Dizdar
    • Mutlu Hayran

    Gastrointestinal Oncology 22 November 2017 Pages: 620 - 620

48. In Reply: Centralization of Upper Gastrointestinal Cancer Care Should Be Dictated by Quality of Care

    • Daniel Henneman
    • Johan L. Dikken
    • Michel W. J. M. Wouters

    Gastrointestinal Oncology 13 November 2017 Pages: 621 - 622

49. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Trial Results of a Phase 2, Randomized, Clinical Trial

    • Peng Wang
    • Zhi-xiang Zhou

    Gastrointestinal Oncology 26 October 2017 Pages: 623 - 623

50. Comment on: Open versus Minimally Invasive Resection of Gastric GIST: A Multi-institutional Analysis of Short- and Long-Term Outcomes

    • S. A. Godhi
    • K. Sisodia
    • P. K. Mishra

    Gastrointestinal Oncology 14 November 2017 Pages: 624 - 625